SUMMARY In a comparative trial minocycline was the best oral tetracycline compound for twicedaily administration in the treatment of non-specific urethritis. A review six months later showed that 29 % of patients had needed further treatment, 35 % of these more than one month after initial treatment and 12 % between three and six months later. The history revealed no evidence of predisposition to non-specific urethritis among patients in whom relapse occurred. Multiple relapses were in the groups of patients who relapsed earliest. These cases proved more resistant to subsequent treatment, but all patients were eventually cured. The records of female contacts showed that 29 % were symptomatic, 44 % had an abnormal appearance of the cervix, but only 11 % had inflammatory changes detected on cytological smear. A previous report was confirmed that there was no apparent benefit from the empirical treatment of contacts; possible reasons for this are given.
Introduction
Material and methods
The cure rate for non-specific urethritis (NSU) is consistently lower than that for most other sexually transmitted diseases of known aetiology. In this trial two drugs which have been reported to be particularly effective are compared with low-dose oxytetracycline (250 mg twice daily). Minocycline (Minocin), 200 mg immediately and 100 mg twice daily for seven days, was found to have a threemonth retreatment rate of 1044% (Willcox et al., 1975) , and sustained-release oral tetracycline (Tetrabid-Organon), 500 mg immediately and 250 mg twice daily for seven days, is recorded as having a 1-3 % failure rate four weeks after treatment (Perera, 1975) . A previous finding that as many as 10 (13 %) out of 76 relapses occurred during the third month after treatment (Evans, 1977) led to the patients in the present trial being assessed after three months and again after six months, and also to multiple relapses being recorded. The (Evans, 1977) (Figure) . There was no difference between the three treatment groups in this respect (Table 3) . Subsequent treatment did not form part of the trial, but it was found that between 36% and 63% (mean 44%) of those who required further treatment had another relapse (Table 3) . A history of NSU more than one year previously was given by 78 patients who were adequately assessed, and of these 43 were cured (23% of total cured) and 35 relapsed (27 % of total who had relapses). Previous NSU did not correlate with unsuccessful treatment, and it did not correlate with repeated relapse (Table 4) .
Patients for whom contacts had attended were grouped according to their own responses to treatment (Table 5 ). This shows no significant difference between the relapse and no relapse groups (x1-2 0-281, p > 0-5), and confirms the findings of an earlier paper (Evans, 1977) .
Sixty-six female contacts of 64 patients attended and their clinical and laboratory findings are (Table 2) , and may be attributable to its greater lipophilicity facilitating higher tissue levels of the antibiotic (Macdonald et al., 1973 Analysis of empirical treatment of contacts confirmed the previously reported conclusion (Evans, 1977) that neither partner appeared to benefit ( Table 5 ), and that the relapse rate was as high among patients whose contacts were treated as among those whose contacts were not. It is conceivable that failure was caused by the contact not complying with the treatment and thus remaining 'infected' with a causal agent of NSU. Scrutiny of various clinical and laboratory findings may therefore reveal some difference in these contacts compared with those of patients who did not relapse, since this group would include contacts who were 'uninfected' before treatment. (Evans, 1976) so that a figure of only 11 % seems improbable in contacts of NSU.
The insuperable failure rate of NSU treatment may well be determined by a number of essentially psychological factors. Preoccupation with a previously ignored but sexually significant site, leading to excessive self-examination and therefore continual physical irritation, is well known to venereologists; these patients are sometimes referred to as 'squeezers'. That this phenomenon should occur in NSU but not in gonorrhoea can be explained by the more gradual onset and slower response to treatment characteristic of NSU, leaving the patient with a longer period in which to develop the habit. Disregard of other aggravating factors such as continued sexual intercourse and alcohol consumption may also lead to relapse.
One explanation for these findings is that the man may acquire sufficient local immunity after adequate treatment of his initial infection to be able to resist reinfection for several weeks, during which time the infecting agent can be eliminated spontaneously by the woman in whom it appears to be of low pathogenicity. Thus, early relapses are caused by inadequate resolution of the original urethritis and later relapses by reinfection. This is supported by the isolation of Chlamydia trachomatis only in patients in whom relapse occurred more than six weeks after treatment (Handsfield et al., 1976) , and by the finding that only 15 % of patients who relapsed within four weeks of treatment gave a history of re-exposure (Evans, 1977) . It is also consistent with the present finding that minocycline reduces the incidence of early relapse but not the incidence of late relapse, since it would not be expected to protect against reinfection. 
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